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Abstract
Gene set analysis allows the inclusion of knowledge from established gene sets, such as gene pathways, and potentially
improves the power of detecting differentially expressed genes. However, conventional methods of gene set analysis focus
on gene marginal effects in a gene set, and ignore gene interactions which may contribute to complex human diseases. In
this study, we propose a method of gene interaction enrichment analysis, which incorporates knowledge of predefined
gene sets (e.g. gene pathways) to identify enriched gene interaction effects on a phenotype of interest. In our proposed
method, we also discuss the reduction of irrelevant genes and the extraction of a core set of gene interactions for an
identified gene set, which contribute to the statistical variation of a phenotype of interest. The utility of our method is
demonstrated through analyses on two publicly available microarray datasets. The results show that our method can
identify gene sets that show strong gene interaction enrichments. The enriched gene interactions identified by our method
may provide clues to new gene regulation mechanisms related to the studied phenotypes. In summary, our method offers a
powerful tool for researchers to exhaustively examine the large numbers of gene interactions associated with complex
human diseases, and can be a useful complement to classical gene set analyses which only considers single genes in a gene
set.
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Introduction
The application of microarray technology has been stimulating
methodological development on data analysis that help biologists
to gain more insights into biological functions of genes.
Conventional statistical analysis methods for gene expression
data mainly aim to discover individual genes whose expression
changes are associated with a phenotype of interest [1–3]. An
extension and enhancement to these individual-gene analyses is
‘‘gene set analysis’’. Gene set analysis utilizes known knowledge of
gene sets, such as gene pathways [4], to discover gene sets the
expressions of which are associated with a phenotype of interest.
Focusing on sets of genes rather than individual genes has at least
two benefits: 1) integrating expression changes of genes inside the
same gene set can reduces the dimensionality of the dataset and
potentially achieve a greater power for detecting differentially
expressed genes, even when the expression changes of individual
genes are modest; 2) gene set analysis incorporates known
biological knowledge. This allows biologists to interpret the
microarray data in a manner that is not possible when it is viewed
as a collection of individual genes [4] and enhances our ability to
understand the functional mechanism that underlies complex
human diseases.
A number of gene set analysis methods have been introduced in the
last few years[5–10]. However, amajor challenge forgene set analyses
is to discover the interactions amonggenes, hidden in gene expressions
data. Members of a gene set (e.g. a gene pathway) can interact with
each other, and these gene interactions can be associated with the
phenotype of interest [11]. Previous studies have demonstrated the
presence and importance of gene interactions in contributing to
complex human diseases [12–18]. Thus ignoring gene interactions in
gene set analyses can hinder our ability in understanding the gene
regulation mechanism underlying human complex diseases.
The purpose of this study is to identify gene interaction
enrichments that are associated with a phenotype of interest. We
propose a method of gene interaction enrichment analysis in the
framework of gene set analysis [8]. We refer to our proposed
method as ‘‘Interaction-based Gene Set Analysis’’ (IB-GSA). We
apply our method to two publicly available microarray datasets.
The results show that our method can identify the gene sets
enriched with gene interactions, which conventional methods of
gene set analysis ignore or are unable to discover. Identified gene
sets and corresponding gene interactions may highlight the
underlying gene regulation mechanism that contributes to
complex human diseases. Overall, our method provides a
complementary approach for identifying gene sets associated with
a phenotype of interest, when gene interactions in a gene set are
enriched and associated with the studied phenotype.
Materials and Methods
For simplicity, we focus on two-gene interactions in a
microarray experiment with expression profiles from samples in
two classes, e.g. presence and absence of a disease. For a gene set S
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expression profile consists of m genes and nk samples. These data
can be represented by a m6nk matrix X(S)k=(xivk)( i=1,…, m;
v=1,…,nk), where xivk is the gene expression level for the i-th gene
of the v-th individual in class k. Let Y (yvk=k) be a vector of the
phenotypes for samples.
Gene Interaction Enrichment Analysis
IB-GSA method is to test the null hypothesis that there is no
gene interaction enrichment in S. When multiple gene sets in a
database are evaluated, the estimated significance levels are
adjusted for multiple hypothesis testing. Three key steps of our
method are outlined as following:
Step 1: Measure of gene interaction information. For
genes i and j, neither may have effect on a phenotype of interest.
However, when they are jointly considered, they may have a
significant effect on the studied phenotype due to the gene-gene
interaction. In gene expression data, interaction between gene i
and gene j can be represented by the difference of co-variances or
correlations between gene i and gene j from two different classes.
Prior to performing gene interaction analysis, the expression
profile of each gene is standardized by its mean and standard
deviation in each class. For example, for gene i in the gene set S, its
expression profile in class k is standardized as following:
x
0
ivk~
xivk{  x xik
sik
ð1Þ
where   x xik and sik are the mean and standard deviation of
expression profile for gene i in class k. After the standardization, a
gene interaction term of genes i and j 1ƒivjƒm ðÞ in class k can
be defined as a cross product of expression profiles of genes i and j
as following [19]:
Ii ,j ðÞ vk~ x
0
ivk   x
0
jvk
  
i,j[S ðÞ ð 2Þ
When the phenotype is binary (i.e., has two classes), whether
there is an interaction between gene expression profiles is to test
whether the mean cross-products are different across these two
classes. Symbolically, this is to test whether
P
v Ii ,j ðÞ v0
 
n0 and P
v Ii ,j ðÞ v1
 
n1 are different. For the case with two genes (gene i
and j), the mean cross-product in a specific class is equivalent to
the correlations between the expression levels of the two genes in
this class:
P
v Ii ,j ðÞ vk
nk
~
P
v x
0
ivkx
0
jvk
nk
~cor i,j ðÞ k
That is, for the case with two genes, the interaction can also
tested by comparing the Pearson correlations of expression levels
for the two genes in the two classes.
Step 2: Calculation of gene set score. We adopt the
‘‘maxmean’’ statistic [8] to calculate a gene set score that reflects
the degree of gene interaction enrichment for the gene set S. The
procedure is briefly described below:
N Calculate the association between the studied phenotype and
each Ii ,jji,j[S ðÞ generated from step 1. In this study we use
t-statistic to test whether there is a difference between P
v Ii ,j ðÞ v0
 
n0 and
P
v Ii ,j ðÞ v1
 
n1, and then transform each
t-statistic value tij to zij i,j[S;1ƒivjƒm ðÞ . The transforma-
tion is zij~W{1 Fn{2 tij
     
,w h e r eW is the cumulative
distribution function (cdf) for a standard normal distribution
and Fn-2 is the cdf for a t distribution with n-2 degrees of
freedom.
N Calculate the ‘‘maxmean’’ statistic T(S) for the gene set S,
which is defined as:
TS ðÞ ~max   s s z ðÞ ,   s s { ðÞ
  
ð3Þ
where
  s s z ðÞ ~
2
mm {1 ðÞ
X
i,j[S
ivj ðÞ
z
z ðÞ
ij and   s s { ðÞ ~{
2
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That is,   s s z ðÞand   s s { ðÞare the averages of the positive and
negative z-values in the gene set S, respectively.
Step 3: Permutation test and multiple testing correction
for multiple gene sets. To determine if T (S) of the gene set S
is statistically significant, we implement a permutation method,
‘‘restandardization’’, proposed by Efron and Tibshirani (for
details, please refer to reference 8). A large number (B)o f
restandardized permutations are carried out to generate the
nominal p value for each gene set. In this study we carry out 1,000
restandardized permutations. The empirical p-value of the gene set
S is the fraction of restandardized permutation values T
B(S) that
exceed (or fall below) the observed value T(S):
pS ðÞ ~# TB S ðÞ wTS ðÞ
    
B or pS ðÞ ~# TB S ðÞ vTS ðÞ
    
B ð4Þ
When multiple gene sets are evaluated, we adjust the estimated
significance level to account for multiple hypothesis testing
through a standard Benjamini-Hochberg [20] FDR analysis.
Core Set Extraction for a Significant Gene Set
In reality, when we identify a gene set with enriched gene
interactions, it is likely that only a subset of genes in the gene set of
interest is associated with the studied phenotype [21,22]. Thus for
each identified gene set with enriched gene interactions, we will
extract a core set of gene pairs that chiefly contribute to the
statistical variation of a phenotype of interest. The ‘‘core set’’ for
the given gene set is a subset that are expected to be more likely
associated with the phenotype. Given a statistically significant gene
set S in gene interaction enrichment analysis, we first calculate the
association strength with the phenotype for each gene pair as
mentioned above, and then they are sorted in decreasing order of
the association strength with the phenotype, z1$z2$…$zs. Select
the first L genes (L=1,…, s) to form a subset RL. The association
statistic with the phenotype for the subset RL is defined as
TRL~
PL
j~1 zj
L
L~1,..., s ðÞ ð 5Þ
We define a p-value, pL for each subset RL based on the
permutation of phenotypic data. In this study we carry out 10,000
permutations, and we calculate the p-value for the L-th subset of
the observed data as
Gene Interaction Enrichment
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The ‘‘core set’’ for the given gene set corresponds to the subset
with the minimum p-value over all the subsets [22].
Results
In this section, we explore the ability of our method to detect the
gene sets in which gene interactions are enriched and associated
with a phenotype of interest in two microarray data sets: ‘‘p53
cancer data’’ and ‘‘lung cancer data’’. The predefined gene sets
are obtained from ‘‘The Molecular Signatures Database’’
(MSigDB), which includes 639 sets containing genes whose
products are involved in specific metabolic and signaling
pathways, as reported in 12 publicly available, manually curated
databases. In our analyses, we only use gene sets with at least 15
members observed in microarray data [4]. We perform two types
of analyses: 1) detecting the enrichment of gene interactions in
gene sets without considering gene marginal effects, as described in
the method section and referred as ‘‘gene interaction analysis’’. 2)
detecting the gene marginal effects in gene sets without gene
interactions, as proposed by Efron and Tibshirani [8] with the
‘‘maxmean’’ statistic and referred as ‘‘main gene analysis’’.
p53 Data Set
The p53 data set contains 50 cell lines. In each cell line, the
expression profiles with 10,100 transcripts were obtained after
quality control. Out of 50 cell lines, 17 cell lines were classified as
normal p53 status while the remaining 33 cell lines carried
mutations in the gene of p53. The protein p53 is a transcription
factor and acts as a cancer suppressor preventing the development
of cancer cells [23]. It regulates genes involved in many key events
of cell life such as those regulating cell cycle checkpoints, DNA
repair, cell growth, differentiation, apoptosis, and senescence [24].
Results for our analyses are summarized in Table 1. At FDR
0.20 level, in ‘‘gene interaction analysis’’ we identify five gene
pathways as significantly associated with p53 mutation status: (i)
VEGF signaling pathway; (ii) Gamma hexachlorocyclohexane
degradation pathway; (iii) Urea cycle and metabolism of amino
groups; (iv) Ether lipid metabolism pathway; and (v) Insulin
signaling pathway. These five pathways, however, do not reach the
significant level in ‘‘main gene analysis’’. It suggests that gene
regulation patterns of these five pathways may be mainly
dependent on the gene interactions (gene correlation changes
across two classes), not on the changes of gene expression levels.
Thus, when two gene regulation patterns, one mainly dependent
on gene interactions and the other on gene expression changes,
exist in the p53 dataset, ‘‘gene interaction analysis’’ and ‘‘main
gene analysis’’ can complement to each other and give us much
biological insights into the genetic regulatory mechanisms of p53
in cancer development.
Taking VEGF signaling pathway as an example, we further
extract a core set of gene pairs that chiefly contribute to the
variation of p53 status. VEGF signaling pathway is involved in
vasculogenesis (e.g. cancer angiogenesis), arteriogenesis, and
lymphangiogenesis as well as in both physiological and patho-
physiological angiogenesis [25]. By our method, we derive a core
set (p,1.00e-4) for VEGF signaling pathway, including 187 gene
pairs. We illustrate the four gene pairs with top gene interaction
effects from VEGF signaling pathway are: 1) KDR and MAPK1;
2) AKT2 and NFATC1; 3) PLA2G10 and PLA2G1B; and 4)
PLA2G10 and PLA2G5. As pointed out above, a two-gene
interaction effect reflects the change of correlation coefficients of a
gene pair in different groups. For the four identified gene pairs,
they show strong positive correlations in the normal group, but
lower negative or no clear correlation in the mutation group, as
shown in Figure 1. For example, for genes KDR and MAPK1,
their correlation coefficient is 0.63 in p53 normal group, but 0.01
in the p53 mutation group. Certain genes in these identified gene
pairs have been linked to p53 status in the cells by previous studies.
Table 1. Summary of ‘‘Gene interaction analysis’’ and ‘‘Main gene analysis’’ for p53 data set.
Gene interaction analysis Main gene analysis
Gene set name FDR Gene set name FDR
VEGF signaling pathway ,0.01 HSP27 pathway ,0.01
Gamma hexachlorocyclohexane degradation pathway 0.09 P53 Hypoxia pathway ,0.01
Urea cycle and metabolism of amino groups pathway 0.09 P53 pathway ,0.01
Ether lipid metabolism pathway 0.09 SA G1 and S phases pathway ,0.01
Insulin signaling pathway 0.15 FMLP pathway ,0.01
NGF pathway ,0.01
RAS pathway ,0.01
doi:10.1371/journal.pone.0008064.t001
Figure 1. Correlation coefficients of four gene pairs from the
VEGF signaling pathway in two different classes.
doi:10.1371/journal.pone.0008064.g001
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damage induced apoptosis. Gene p53 acts as one of the upstream
regulators of MAPK1 activation for the induction of apoptosis in
cancer cells, and the p53 status can affect the activation MAPK1
[26,27].
Lung Cancer Data Set
The lung cancer data set consists of samples from 86 patients, of
which 24 were dead and 62 survived. The gene expression profile
of each sample contains 5,217 probes. Our analysis results are
summarized in Table 2. At FDR 0.20 level, we identify two
pathways by ‘‘gene interaction analysis’’: (i) GSK3 pathway; and
(ii) Androgen and estrogen metabolism pathway, which do not
reach the significant level in ‘‘main gene analysis’’, indicating that
these two pathways are mainly dependent on two-gene interac-
tions to involve in gene regulation of lung cancer.
To illustrate the effects of gene interactions, we focus on the
GSK3 pathway. By our method, we extract a core set (p,1.00e-4)
for the GSK3 pathway, including 39 gene pairs. The four pairs
with top gene interaction effects from it: 1) APC and NFKB1; 2)
AKT1 and NFKB1; 3) DVL1 and MYD88; and 4) PPP2CA and
WNT10B. As shown in Figure 2, these four gene pairs show
negative correlation in the dead group, and lower positive
correlation or no clear correlation in the survival group. For
example, for genes APC and NFKB1, their correlation is -0.60 in
the dead group, but 0.03 in the survival group. Biologically,
previous studies have shown that APC is associated with cancer
recurrence [28], and AKT1 are associated with several different
cancers, such as breast, colorectal, and lung cancers [29]. Thus
those gene interactions identified by our method may provide new
clue for the gene regulatory mechanisms which are associated with
lung cancer.
Discussion
Although a number of gene set analysis methods have been
proposed, they provide little information on gene interactions.
However, as gene interactions in a gene set may be associated with
the studied phenotype, it is useful for finding potential gene
regulation patterns from gene expression data. A computational
and statistical challenge in identifying gene interactions in
microarray data is that the number of possible gene interactions
increases exponentially with the number of genes and that a large
number of tests are involved.
In this study, our method not only tests gene interactions in the
framework of gene set enrichment analysis, but also extracts core
sets of gene interactions that contribute to the variation of a
phenotype of interest. More importantly, our method provides a
way to integrate these three analyses for identifying target genes
and gene interactions related to the trait of interest. Using two
publicly available datasets, we have shown how our method can be
applied to analyze gene interaction enrichment. The results
indicate that our method can discover gene sets with enriched
gene interactions hidden in microarray data. In addition, our
method is advantageous in that the use of the minimum p-value
can reduce the irrelevant gene combinations and extract core sets
of gene interactions that chiefly contribute to the statistical
variation of a phenotype of interest. Exploration of core sets of
gene interactions is a useful step towards further understanding
biological mechanisms underlying the gene-set association with the
phenotype of interest. The identified gene interactions can be used
in the gene regulation construction to investigate a fine structure of
the gene regulation patterns that are associated with studied
phenotype.
In our method, cross products of gene expression profiles are
adopted to identify gene interactions in a gene set. Using cross
product term of gene expression profiles, it has two main
advantages: 1) this general idea can be extended straightforwardly
to test higher-order interaction effects among gene expression
profiles for gene expression data. For example, we can test three-
gene interactions by using cross-products of three gene expression
profiles. Different patterns of gene interactions may produce
further insights in the analysis of gene regulation structures; 2) this
method can be not only applied to a binary trait, but also a
continuous trait for gene interaction analyses. Thus our method
provides a general methodology for gene interaction enrichment
analysis for gene expression data.
In summary, gene interaction enrichment analysis is a natural
exploration step forward for methodologies of gene set analysis.
With gene interactions being a basis for the very active field of
regulatory network construction [31,32], our method can give
researchers the ability to extract potentially disease-related gene
sets and related genes from microarray data, and thus is helpful to
delineate the sophisticated knowledge of relevant molecular
pathways of disease pathogenesis. Our method can be a useful
complement to classical gene set analysis which only considers the
single genes in a gene set.
Web Resources
The URLs for data presented herein are as follows:
P 53 and Lung cancer datasets: http://www.broad.mit.edu/
gsea/index.jsp
MSigDB: http://www.broad.mit.edu/gsea/msigdb/index.jsp
Table 2. Summary of ‘‘Gene interaction analysis’’ and ‘‘Main
gene analysis’’ for lung cancer data.
Gene interaction analysis Main gene analysis
Gene set name FDR Gene set name FDR
GSK3 pathway ,0.01 Ceramide pathway ,0.01
Androgen and estrogen
metabolism pathway
0.16 AMI pathway ,0.01
CSK pathway ,0.01
doi:10.1371/journal.pone.0008064.t002
Figure 2. Correlation coefficients of four gene pairs from the
GSK3 pathway in two different classes.
doi:10.1371/journal.pone.0008064.g002
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